Heraeus Increases Production Capacity for PV Paste at Singapore Facility

Heraeus' Photovoltaics Business Unit is increasing their production capacity at its site in Singapore. As Pete Horan, Vice President Operations, points out, "ever since we built our Singapore factory we have seen increasing concentration of our customer base in Asia. I expect our paste production volume in Singapore to increase significantly over the next years."

Heraeus will continue production at its site in West Conshohocken, Pennsylvania, where it had recently enhanced its R&D capabilities. In parallel, the site in Hanau, Germany will concentrate on Technical Service and Applications. Andreas Liebheit, Senior Vice President managing the Photovoltaics Business Unit adds: "Bringing even more of our Production Capacity close to our prominent Asian partners, our Singapore site will become even more important in the future. Being able to meet increasing demand at reasonable lead times is the key to success in the fast moving PV industry. Moreover this South-East Asian operation provides a perfect environment for continuous improvements in lean management throughout the entire supply chain and manufacturing process."

Increasing production capacity at its Singapore site underlines Heraeus' continued strong commitment to the PV market. Heraeus has been a technology leader in silver paste ever since it entered this industry in 2008.

About the Heraeus Photovoltaics Business Unit

The Heraeus Photovoltaics Business Unit is an industry leading developer and manufacturer of silver metallization pastes for the photovoltaic industry. For over 40 years, Heraeus has built a reputation of innovation, extensive research and new product development in thick film technologies for some of the most prominent companies within a variety of industries. In the field of photovoltaics, the Heraeus Photovoltaics Business Unit applies this history and its innovative technology to offer metallization pastes for solar cell applications. The Heraeus SOL Series of silver pastes is specially formulated to provide higher efficiencies and wider processing windows, resulting in better yields and higher output for cell manufacturers.

Heraeus, the precious metals and technology group headquartered in Hanau, Germany, is a global, private company with more than 160 years of tradition. Our fields of competence include precious metals, materials and technologies, sensors, biomaterials and medical products, quartz glass, and specialty light sources. In the financial year 2012 Heraeus generated product revenues of €4.2 billion and precious metal trading revenues of €16 billion. With more than 12,200 employees in over 100 subsidiaries worldwide, Heraeus holds a leading position in its global markets.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Heraeus Holding GmbH. (2019, February 08). Heraeus Increases Production Capacity for PV Paste at Singapore Facility. AZoM. Retrieved on November 23, 2024 from https://www.azom.com/news.aspx?newsID=39349.

  • MLA

    Heraeus Holding GmbH. "Heraeus Increases Production Capacity for PV Paste at Singapore Facility". AZoM. 23 November 2024. <https://www.azom.com/news.aspx?newsID=39349>.

  • Chicago

    Heraeus Holding GmbH. "Heraeus Increases Production Capacity for PV Paste at Singapore Facility". AZoM. https://www.azom.com/news.aspx?newsID=39349. (accessed November 23, 2024).

  • Harvard

    Heraeus Holding GmbH. 2019. Heraeus Increases Production Capacity for PV Paste at Singapore Facility. AZoM, viewed 23 November 2024, https://www.azom.com/news.aspx?newsID=39349.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.